Shanghai Retained Earnings from 2010 to 2025

688217 Stock   19.59  0.01  0.05%   
Shanghai Rightongene's Retained Earnings are increasing over the years with slightly volatile fluctuation. Retained Earnings are expected to dwindle to about 115.2 M. Retained Earnings is the cumulative amount of net income that Shanghai Rightongene Biotechnology retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2010-12-31
Previous Quarter
177.1 M
Current Value
115.2 M
Quarterly Volatility
55.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai Rightongene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Rightongene's main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 2.8 M or Interest Expense of 1 M, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Rightongene Valuation or Volatility modules.
  
This module can also supplement various Shanghai Rightongene Technical models . Check out the analysis of Shanghai Rightongene Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.